A PHARMACEUTICAL giant, May & Baker Nig. Plc., has said that it is working towards producing a range of new products aimed at promoting healthy living.
According to the News Agency of Nigeria (NAN), Head of Pharma Sales and Marketing of the firm, Obinna Emeribe, said that the firm had planned to launch, at least, seven new products before the end of 2024.

According to Emeribe, besides many corporate social responsibilities, May & Baker is working with research centres in Nigeria, including the National Institute for Pharmaceutical Research and Development (NIPRD), Abuja, to commercialise medicines for management of sickle cell anaemia.

“May & Baker is partnering with NIPRD, which has the lead to the establishment of our herbal plant at Ota.

“In the next one or two months, another product of research by a Nigerian professor, called Rofeda – the bitter leaf capsule – is going to be commercialised in Nigeria by May & Baker, courtesy of our herbal plant.”

“There are very important ingredients in the normal bitter leaf we eat that help the human life.

“Our continued investment in research and development, focus on harnessing cutting-edge technologies, and commitment to collaborations and partnerships will guide us as we navigate the ever-changing landscape of healthcare,” he said.

Besides, the firm said that it is celebrating its 80th anniversary with re-commitment to promoting healthcare in Nigeria through production of medical products of international standards.

Managing Director of the company, Patrick Ajah, gave the assurance during a media briefing, yesterday, in Lagos. Ajah, who described the celebration as landmark, said: “In 2008, the company started construction of a pharma centre, a WHO-standard pharmaceutical products outfit, which was commissioned on June 27, 2011, and it has the capacity to produce about six billion tablets and 37.5 million of liquids every year.

“In commemoration of the 80th anniversary, we have decided to give back to the society through some projects in key areas of need.”